Sublimity Therapeutics closes financing to fund development of STI-0529 in ulcerative colitis May 23, 2018
Acceleron initiates phase II PULSAR study of sotatercept in pulmonary arterial hypertension May 23, 2018
Allergy Therapeutics reports promising topline results from phase II trial of Grass MATA MPL May 22, 2018
RSS